PHOENIX NEW MED.ADR 1/48 (1PX) — Tangible Net Worth Ratio
PHOENIX NEW MED.ADR 1/48 (1PX) has a Tangible Net Worth Ratio of 99.1% as of December 2025. This metric is calculated by deducting intangible assets (€10.41 Million) from net assets (€1.11 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 1PX shareholders equity momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
PHOENIX NEW MED.ADR 1/48 Tangible Net Worth Ratio (2021–2025)
This chart shows how PHOENIX NEW MED.ADR 1/48's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 99.1%, reflecting net assets of €1.11 Billion with intangible assets of €10.41 Million EUR. For live market cap and overall valuation, see 1PX company net worth.
Annual Tangible Net Worth Ratio for PHOENIX NEW MED.ADR 1/48 (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for PHOENIX NEW MED.ADR 1/48 from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See PHOENIX NEW MED.ADR 1/48 (1PX) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.1% | €1.11 Billion | €10.41 Million | €1.65 Billion | ▲ +0.3 pp |
| 2024 | 98.8% | €1.11 Billion | €13.72 Million | €1.71 Billion | ▲ +0.5 pp |
| 2023 | 98.3% | €1.16 Billion | €20.05 Million | €1.76 Billion | ▲ +0.6 pp |
| 2022 | 97.7% | €1.27 Billion | €29.13 Million | €2.03 Billion | ▼ -0.7 pp |
| 2021 | 98.4% | €1.39 Billion | €22.50 Million | €2.41 Billion | — |